MSc Cancer Molecular Pathology and Therapeutics

The Cancer Molecular Pathology and Therapeutics MSc course is a full-time program delivered by the University of Leicester. The course is specially designed for graduates aspiring to careers in the healthcare sector with a particular interest in cancer therapies, whether laboratory-based or clinical research. This course provides a comprehensive and hands-on approach to understanding cancer as a disease process.Course Content: The program encompasses a blend of theoretical study, practical sessions and research. Key focus areas include emerging technologies and how these can help in the diagnosis and treatment of disease, genomics of cancer, cell and molecular biology, diagnostic histopathology, cancer immunology, cancer therapeutics, and clinical pathology. The course runs through two semesters, followed by a research project in the summer.Key Modules: Some of the essential modules include 'Cancer Cell and Molecular Biology,' 'Cancer Genetics,' 'Diagnostic Pathology and Lab Medicine,' 'Research Project,' 'Cancer Immunology,' 'Cell and Tissue Imaging,' 'Cancer Genomics' and 'Cancer Therapeutics.'Accreditations: While specific accreditations are not stated, the University of Leicester is a recognized institution, and the program itself is closely aligned with current professional practices.Future Careers: With the knowledge and experience gained from this MSc course, graduates are prepared for a wide range of careers. These include roles in biomedical research, healthcare scientific and technical roles, scientists, or research managers in the Pharmaceutical industry, stage-managers in the field of clinical trials, roles in science communication, teaching, and scientific writing.For more information on this course, please visit the official course page.